Navigation Links
Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
Date:1/21/2009

posity, glucose metabolism, and lipid metabolism. For edema, associations were found among the genes involved in vascular inflammation or regulation, lipid metabolism and glucose metabolism.

"For the first time in diabetic care, we can assess that genes in interlocking cardiometabolic and neuroendocrine pathways can be integrated into a PhyzioType System, a multi-gene array and clinical model predictive of drug side effects," said Gualberto Ruano, M.D., Ph.D., President and CEO of Genomas. "Our existing PhyzioType Systems for statin neuro-myopathy and antipsychotic-related diabetes are now being complemented by a third one for TZD-induced cardiovascular side effects for comprehensive DNA-guided medicine in modern healthcare."

ABOUT GENOMAS

Genomas(R) Inc. is a biomedical company advancing DNA-guided medicine and personalized healthcare. The company develops revolutionary PhyzioType(TM) Systems for DNA-guided diagnosis and prevention of metabolic disorders induced by drugs used to treat diabetes, and cardiovascular and psychiatric illnesses. PhyzioType Systems are designed to provide physicians with an unprecedented capability to select for each patient the safest drug treatment to enhance compliance. Genomas is located in Hartford, CT on the campus of Hartford Hospital. Please visit www.genomas.net for more information.


'/>"/>
SOURCE Genomas Inc.
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related biology technology :

1. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
2. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
3. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
4. Amarin Announces Initiation of Cardiovascular Development Strategy
5. VIA Pharmaceuticals Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Informations Therapeutic Area Partnerships Conference
6. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
7. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
8. HealthAware Introduces Its VascularAware Cardiovascular Disease Module
9. Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
10. BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
11. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., SEATTLE, Nov. 20 Cell ...nounced today that the Ninth Circuit Court of Appe... that CTI should be allowed to pursue all of its c...k to the District Court for trial. CTI filed a co...-party reimbursement consultant for CTI,s product ...
(Date:11/19/2009)...ENHAGEN, Nov. 19 Danish Prince Joa...losic ethanol plant in Kalundborg, Denmark, on Wed...rld,s first and largest 2nd generation ethanol dem...nzymes are used in the plant,s innovative process ... of Danisco, was the first to market with commerci...
(Date:11/19/2009)...W YORK, Nov. 19 NeoStem,...has sent the following letter to its shareholders,...30, 2009, of China Biopharmaceuticals Holdings, In...y based in the People,s Republic of China. The mer...zhou Eyre Pharmaceutical Co. Ltd., CHBP,s primary ...
(Date:11/19/2009)...NTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics...ent in a randomized Phase 2B study of AEG35156, a ...pment for multiple oncology indications. ,, The... Study of the X-Linked Inhibitor of Apoptosis (XIA...gh-dose Cytarabine and Idarubicin in AML Following...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...EN, Italy, February 23 Health Robotics and Can-Me...ve agreement whereby Can-Med,has acquired the excl...TATION robot in Armenia, Georgia, Kazakhstan, Uzbe...yrgyzstan, and Tajikistan. i.v.STATION is the,worl...buted, and fail-safe,robotic system for the steril...
...RTH, N.J. and BOXMEER, Netherlands, Feb. 23 Scher...ced a license agreement between Nobilon, Schering-...d Health Organization (WHO) to provide access to p... to developing countries. , , Fred Hassan, chairm...ing-Plough,s strong commitment to innovation and t...
...NTO, Calif., Feb. 23 CUREXO Technology Corporatio... image-directed robotic products for orthopaedic a...ODOC(R) Surgical System, announced today that they...iation of Orthopaedic Surgeons Annual Conference a...h through the 27th, Booth #3456. , , For the firs...
Other Biology Technology:Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia 2Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia 3Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries 2Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries 3CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas 2
(Date:11/23/2009)... highest resolution images of peptides attaching t...standing how biomolecules manipulate the growth cr...for kidney stones using biomolecules. , The rese...of the journal Proceedings of the National Academ...h mineral surfaces by accelerating, switching and ...
(Date:11/23/2009)...al engineer and cardiologist Tzung "John" Hsiai ho...nguish cardiac emergencies requiring immediate sur...nd lifestyle change. , Angiograms, images made b... heart, offer an inside view of the interior surfa...ng deposits of a dangerous fatty substance called ...
(Date:11/23/2009)...ix-week-old turkey poults could save millions of m...according to Dr. Gerald Steiner from the Dresden U...heir use of infrared spectroscopy to determine the... accurate method with the potential to be used by ...e eggs for breeding. The pilot study has just been...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Rescuing male turkey chicks 2Mercedes Benz Gives to a McDreamy Cause 58818 1Mercedes Benz Gives to a McDreamy Cause 58818 2Mercedes Benz Gives to a McDreamy Cause 58818 3Mercedes Benz Gives to a McDreamy Cause 58818 4InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP T Technology for production of recombinant proteins 10249 1InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP T Technology for production of recombinant proteins 10249 2InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP T Technology for production of recombinant proteins 10249 3Respect Life and the Truth on Respect Life Sunday 58814 1Respect Life and the Truth on Respect Life Sunday 58814 2Respect Life and the Truth on Respect Life Sunday 58814 3
...dress a major problem facing bioengineers as they ... not only form structures, but to stimulate the gr... multidisciplinary team of investigators from Duke...he University of Massachusetts, Amherst created an...thin a specialized solution act like molecular she...
...p people who are not responding to Anti-Retroviral... in The Journal of Immunology . Scientists lookin... to reduce the virus levels in the blood to undete...cule called D-1mT alongside Anti-Retroviral Therap... very similar to Human Immunodeficiency Virus (HIV...
... for the first time, that C. elegans worms crawl a...y accepted belief that these two behaviours are co... implications for biologists and geneticists using...cientists have largely limited their observations ...ery suggests that it is just as important to consi...
Other Biology News:Magnetic nano-'shepherds' organize cells 2Magnetic nano-'shepherds' organize cells 3Potential new HIV drug may help patients not responding to treatment 2Potential new HIV drug may help patients not responding to treatment 3To swim or to crawl: For the worm it's a no brainer 2
...ned for use with the ProQuest Two-Hybrid System (F...etions in the endogenous GAL4 and GAL80 genes for ... also has leu2 and trp1 mutations for selection of...hree GAL4 inducible reporter genes, providing four...
Feline IL-2 ELISpot Kit from R&D Systems
Mouse Anti-Bovine titin Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Rat Anti-Mouse VCAM-1 / CD106 Monoclonal Antibody, Unconjugated, Clone 112702 from R&D Systems
Biology Products: